Results 151 to 160 of about 22,314 (175)

An Uncommon Case of Non-leukemic Myeloid Sarcoma of the Face in a 71-year-old Filipino Female: A Case Report. [PDF]

Acta Med Philipp
Catambing VAH, Gauiran DTV.
europepmc   +1 more source

Epigenetic mechanisms of drug resistance in acute myeloid leukemia: advances in small-molecule targeted therapy. [PDF]

Front Pharmacol
Tang J, Ye X, Xu Z, Min T, Tian Z, Ma L, He Y, Jiang B.   +7 more
europepmc   +1 more source

Preclinical and Case Series Studies on the Combination of Venetoclax with Epigenetic Drugs in T-Cell Acute Lymphoblastic Leukemia. [PDF]

Cancer Manag Res
Zheng B, Fu J, Wang Y, Wu J, Wang J, Li H.   +5 more
europepmc   +1 more source

Molecular and Clinical Insights into <i>TP53</i>-Mutated MDS and AML. [PDF]

Int J Mol Sci
Georgantzinos E, Karantanos T.
europepmc   +1 more source

Epigenetics of cancer : a new way to manage oncology patients [PDF]

, 2014
Martínez-Escardó, L., Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms. [PDF]

Blood Cancer J
Gangat N, Dinardo CD.
europepmc   +1 more source

Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia. [PDF]

Cancer
Bao M, Zhang XS, Li ZR, Yu L, Gale RP, Zhao SS, Ye F, Yan CC, Huang XJ, Jiang Q.   +9 more
europepmc   +1 more source

Digital twin models for predicting venetoclax and azacitidine-induced neutropenia in patients with acute myeloid leukemia. [PDF]

NPJ Digit Med
Zhang Y, Martinez J, Tercan B, Kuusanmäki H, Emmert-Streib F, Chandraseelan JG, Farea A, Yli-Harja O, Heckman CA, Gibbs DL, Thorsson V, Shmulevich I, Kontro M, Qin G, Aguilar B.   +14 more
europepmc   +1 more source

Granulocyte colony-stimulating factor plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia: a multicenter phase 2 trial. [PDF]

Blood Cancer J
Wang H, Wang X, Shi T, Wei S, Li X, Leng Y, Wu Y, Sun M, He P, Zhu HH.   +9 more
europepmc   +1 more source

Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study. [PDF]

Br J Haematol
Schönung M, Rathmann S, Ramamoorthy S, Lebrecht D, Klingebiel T, Locatelli F, Nysom K, Rossig C, Starý J, Zecca M, Patturajan M, Erlacher M, Strahm B, Niemeyer CM, Lipka DB, Flotho C.   +15 more
europepmc   +1 more source